167 related articles for article (PubMed ID: 15897698)
21. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Cox CE
Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
[TBL] [Abstract][Full Text] [Related]
23. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
25. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
[TBL] [Abstract][Full Text] [Related]
26. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
[TBL] [Abstract][Full Text] [Related]
27. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections.
Naber KG; Bartnicki A; Bischoff W; Hanus M; Milutinovic S; van Belle F; Schönwald S; Weitz P; Ankel-Fuchs D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S41-53. PubMed ID: 15037328
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic characteristics of prulifloxacin.
Matera MG
Pulm Pharmacol Ther; 2006; 19 Suppl 1():20-9. PubMed ID: 16360331
[TBL] [Abstract][Full Text] [Related]
29. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
Neringer R; Forsgren A; Hansson C; Ode B
Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
[TBL] [Abstract][Full Text] [Related]
30. [Antibiotic prophylaxis with prulifloxacin in women undergoing induced abortion: a randomized controlled trial].
Caruso S; Di Mari L; Cacciatore A; Mammana G; Agnello C; Cianci A
Minerva Ginecol; 2008 Feb; 60(1):1-5. PubMed ID: 18277346
[TBL] [Abstract][Full Text] [Related]
31. Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.
Cai T; Mazzoli S; Addonisio P; Boddi V; Geppetti P; Bartoletti R
Methods Find Exp Clin Pharmacol; 2010; 32(1):39-45. PubMed ID: 20383345
[TBL] [Abstract][Full Text] [Related]
32. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
Iravani A
Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
[TBL] [Abstract][Full Text] [Related]
33. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
Peng MY
J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
[TBL] [Abstract][Full Text] [Related]
34. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial.
Vogel T; Verreault R; Gourdeau M; Morin M; Grenier-Gosselin L; Rochette L
CMAJ; 2004 Feb; 170(4):469-73. PubMed ID: 14970093
[TBL] [Abstract][Full Text] [Related]
35. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
36. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
Pasqua F; Biscione G; Crigna G; Cazzola M
Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection.
Naber KG; di Silverio F; Geddes A; Guibert J
J Antimicrob Chemother; 1996 May; 37 Suppl A():135-44. PubMed ID: 8737133
[TBL] [Abstract][Full Text] [Related]
38. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
[TBL] [Abstract][Full Text] [Related]
39. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
[TBL] [Abstract][Full Text] [Related]
40. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
Blondeau JM
Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
